Use of a Smartphone Application (App) to Assist a Cognitive-Behavioral Smoking Cessation Treatment

NCT04765813 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 287

Last updated 2023-12-05

No results posted yet for this study

Summary

This randomized controlled clinical trial examines the effectiveness of a face-to-face\* cognitive-behavioral behavioral treatment to quit smoking enriched with an App. This project aims to innovate in the psychological smoking cessation treatment and increase abstinence rates in the short and long term.

\* Due to the COVID-19 the face-to-face treatment will be conducted in an online format.

Conditions

  • Smoking

Interventions

BEHAVIORAL

Cognitive-behavioral treatment to quit smoking along with an App with active therapeutic components

Cognitive-behavioral smoking cessation treatment components will be: treatment contract, self-report and graphic representation of cigarette consumption, information about tobacco, stimulus control, activities for the avoidance of withdrawal syndrome, physiological feedback (CO in expired air) on cigarette consumption, nicotine fading (change of cigarette brands each week progressively decreasing the intake of nicotine and tar), and relapse-prevention strategies (assertion training, problem-solving training, change tobacco-related misconceptions, management of anxiety and anger, exercise, weight control, self-reinforcing, and changing irrational beliefs). Participants will use a smartphone App with therapeutic components during the intervention (8 weeks) and follow-up period (time frame: one year).

BEHAVIORAL

Cognitive-behavioral treatment to quit smoking along with a control App

Cognitive-behavioral smoking cessation treatment components will be: treatment contract, self-report and graphic representation of cigarette consumption, information about tobacco, stimulus control, activities for the avoidance of withdrawal syndrome, physiological feedback (CO in expired air) on cigarette consumption, nicotine fading (change of cigarette brands each week progressively decreasing the intake of nicotine and tar), and relapse-prevention strategies (assertion training, problem-solving training, change tobacco-related misconceptions, management of anxiety and anger, exercise, weight control, self-reinforcing, and changing irrational beliefs). Participants will use a control smartphone App (only to access session materials) during the intervention period (8 weeks).

Sponsors & Collaborators

  • Ministerio de Ciencia e Innovación, Spain

    collaborator OTHER_GOV
  • University of Santiago de Compostela

    lead OTHER

Principal Investigators

  • Elisardo Becoña, PhD · University of Santiago de Compostela

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-15
Primary Completion
2023-11-10
Completion
2023-11-10

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04765813 on ClinicalTrials.gov